ArticleInternational journal of clinical oncology2011

High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer.

Yumi Endo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.